99 related articles for article (PubMed ID: 22185986)
21. [Albumin-to-creatinine ratio as a diagnostic tool for type 2 diabetic nephropathy].
Mundet Tudurí X; Martínez Carmona S; Espinosa González N; López Rodway C; Carrera Font T; Romea Lecumberri S; Gimbert Ràfols R; Martí Montesa J
Med Clin (Barc); 2001 May; 116(19):732-3. PubMed ID: 11412693
[TBL] [Abstract][Full Text] [Related]
22. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
Shao Y; Lv C; Yuan Q; Wang Q
J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
[TBL] [Abstract][Full Text] [Related]
23. The Value of Serum Prolidase Activity in Progression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus.
Sabuncu T; Boduroglu O; Eren MA; Torun AN; Aksoy N
J Clin Lab Anal; 2016 Sep; 30(5):557-62. PubMed ID: 26666214
[TBL] [Abstract][Full Text] [Related]
24. [Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy].
Chen HB; Jia WP; Lu JX; Bao YQ; Li Q; Lu FD; Lu W; Yu HY; Xiang KS
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1230-3. PubMed ID: 17686253
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
26. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.
Soedamah-Muthu SS; Colhoun HM; Taskinen MR; Idzior-Walus B; Fuller JH;
Diabetologia; 2000 Nov; 43(11):1353-9. PubMed ID: 11126402
[TBL] [Abstract][Full Text] [Related]
27. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan.
Tseng CH
Clin Biochem; 2009 Jul; 42(10-11):1019-24. PubMed ID: 19324028
[TBL] [Abstract][Full Text] [Related]
28. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study.
Rossi MC; Nicolucci A; Pellegrini F; Comaschi M; Ceriello A; Cucinotta D; Giorda C; Pomili B; Valentini U; Vespasiani G; De Cosmo S
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):110-6. PubMed ID: 19447588
[TBL] [Abstract][Full Text] [Related]
29. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
[TBL] [Abstract][Full Text] [Related]
30. Association between urinary albumin excretion and low-density lipoprotein heterogeneity following treatment of type 2 diabetes patients with the dipeptidyl peptidase-4 inhibitor, vildagliptin: a pilot study.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2013 Dec; 13(6):443-50. PubMed ID: 23990203
[TBL] [Abstract][Full Text] [Related]
31. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.
Lenghel AR; Kacso IM; Bondor CI; Rusu C; Rahaian R; Gherman Caprioara M
Diabetes Res Clin Pract; 2012 Jan; 95(1):55-61. PubMed ID: 21945031
[TBL] [Abstract][Full Text] [Related]
32. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus.
Feng G; Gao JL; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C
Acta Diabetol; 2017 Nov; 54(11):1047-1055. PubMed ID: 28894973
[TBL] [Abstract][Full Text] [Related]
33. Identification of the stages of diabetic nephropathy at which angiotensin II receptor blockers most effectively suppress albuminuria.
Ogawa S; Matsushima M; Mori T; Okamura M; Senda M; Sakamoto T; Nako K; Ito S
Am J Hypertens; 2013 Sep; 26(9):1064-9. PubMed ID: 23775091
[TBL] [Abstract][Full Text] [Related]
34. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
35. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
[TBL] [Abstract][Full Text] [Related]
36. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
37. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects.
Lee IT; Wang CY; Huang CN; Fu CC; Sheu WH
J Diabetes Complications; 2013; 27(3):243-7. PubMed ID: 23276621
[TBL] [Abstract][Full Text] [Related]
38. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
39. Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient.
Yamagami K; Hosoi M; Yamamoto T; Fukumoto M; Yamakita T; Miyamoto M; Yoshioka K; Ishii T; Sato T; Tanaka S; Fujii S
Diabetes Obes Metab; 2005 Jul; 7(4):390-6. PubMed ID: 15955125
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Role of Tangshenkang Granule () in Rat Model with Diabetic Nephropathy.
Hu SJ; Shu B; Jin H; Li XF; Mao JR; Ren KJ; Gao L; Yang L; Wu YW; Wang YJ
Chin J Integr Med; 2018 Aug; 24(8):600-605. PubMed ID: 27778266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
